Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. Bouxsein ML, Chen P, Glass EV, Kallmes DF, Delmas PD, Mitlak BH. J Bone Joint Surg Am. 2009;91(6):1329–38
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
PII: S1529-9430(10)00046-X
doi:10.1016/j.spinee.2010.01.010
© 2010 Elsevier Inc. All rights reserved.
